Home | News | Directories | Calendar | Maps | A to Z | Contact Us | Webmail
Perelman School of Medicine at the University of Pennsylvania Advanced Search

SOM Stimulus Information

Memorandum

To: School of Medicine Faculty
From: Glen N. Gaulton, Ph.D.
Date: October 21, 2009
Subject: Update on SOM Stimulus Awards and New ARRA Funding Announcements

I write to update you on the American Recovery and Reinvestment Act of 2009.  First, I am pleased to inform you that, as of October 13th (see attachment), the School of Medicine has received 220 ARRA stimulus awards totaling $136.4M from NIH. Of these funds, we have received 29 Challenge grants with $24.4M in total funds, and 7 Grand Opportunity grants totaling $38M. A full report on these efforts and outcomes can now be found on our updated SOM Stimulus website.

This outstanding response is tied to a remarkable number of submissions: 1,166 proposals requesting $852.3M in total project costs. The extraordinary number of submissions and accelerated review process means that many excellent proposals went unfunded. Where possible, I encourage you to submit these via “normal” NIH venues.

It is also possible to track Penn’s progress in receipt of ARRA stimulus funding in comparison to other institutions on the NIH Recovery Act website. Not surprisingly, we have also done remarkably well from this perspective.

The second item is in regard to faculty support for hiring new employees. I encourage anyone who needs assistance with Human Resources processes as a result of ARRA funding to please visit the HR Stimulus Website. For assistance with recruiting biomedical postdocs, please visit the Biomedical Postdoctoral Programs (BPP) website. In addition to providing a centralized site for posting postdoctoral training and research job opportunities at Penn, BPP can also provide resumes of available biomedical postdoctoral candidates. Additional information regarding the ARRA reporting requirements is forthcoming from the University and I will keep you updated on these as they are released.

Lastly, a small number of ARRA funding solicitations are still being released.

  • RFA-HS-10-003: Recovery Act 2009 Limited Competition: AHRQ Clinical and Health Outcomes Initiative in Comparative Effectiveness (CHOICE) Grants (R01)
  • Due December 16, 2009
  • $100M total awards, 10 anticipated.Applications not to exceed $10 million in total project costs over 3 year period.
  • Large projects aimed at generating new knowledge to help inform decision making in priority areas of clinical care. Emphasis on defining important research gaps and ability to provide actionable results. Important to address outcomes and effectiveness of assessments across population subgroups often underrepresented in medical research, including but not limited to racial and ethnic minorities, persons with disabilities, children, elderly, patients with multiple and chronic conditions, and disadvantaged and/or under represented populations for the specific condition being studied. Priority conditions important to the Medicare, Medicaid, and CHIP programs and mandated by the MMA section 1013 are of special interest.
  • Other useful information can be found at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-003.html
  • RFA-HS-10-004: Recovery Act 2009 Limited Competition: Innovative Adaptation and Dissemination of AHRQ Comparative Effectiveness Research Products (iADAPT) (R18)
  • Due December 16, 2009
  • $29.5M total awards, 20-25 anticipated. Applications not to exceed $1.5M in total project costs over 3 year period.
  • Objective to extend research and impact of Comparative Effectiveness Research Reviews and associated products: to bridge gap between research and practice by translating and disseminating findings on the comparative effectiveness of clinical interventions for three broad audiences – patients/consumers, clinicians, and policymakers. Additional adaptations or customizations are aimed at increasing use, implementation, and impact among difficult to reach populations, including elderly, those with limited English proficiency, limited education or insurance coverage, minority or immigrant status, health literacy problems, or other underserved populations.
  • Other useful information can be found at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HS-10-004.html
  • RFA-OD-09-010: Recovery Act 2009 Limited Competition: Building Sustainable Community-Linked Infrastructure to Enable Health Science Research (RC4)
  • Due December 11, 2009
  • $30M total awards, 30 or more to be funded. Applicants may submit more than one application.
  • Seeking transformative collaborative arrangements in support of the development, expansion, or reconfiguration of bi-directional relationships between academic health centers and community entities in the pursuit of improved public health through research. Such collaboration should transform the way in which health science research is conducted in communities, and accelerate the pace, productivity, dissemination, and implementation of health research.
  • Other useful information can be found at: http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-09-010.html

As always, please contact me at stimulus@mail.med.upenn.edu or 215-898-1042 if you need any special institutional assistance to submit a proposal.

Glen N. Gaulton, Ph.D.
Professor of Pathology and Laboratory Medicine
Executive Vice Dean and Chief Scientific Officer
University of Pennsylvania
Perelman School of Medicine
Tel: 215-898-2874 | Fax: 215-573-7945
Email: gaulton@mail.med.upenn.edu     
image